SELE and acute lymphoblastic leukemia: Since E-selectin inhibition on endothelial cells was sufficient to alter clearance kinetics in a diseased ALL mouse (as described in Fig. 2), we wanted to explore whether interfering with E-selectin binding of leukemia cells could affect the observed changes associated with treatment in a different disease model.